American Century Companies Inc Adicet Bio, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024
BUY
$1.21 - $2.4 $17,177 - $34,070
14,196 Added 22.94%
76,087 $92,000
Q1 2024

May 14, 2024
BUY
$1.76 - $3.45 $108,928 - $213,523
61,891 New
61,891 $145,000
Q3 2023

Nov 13, 2023
BUY
$1.37 - $3.4 $6,641 - $16,483
4,848 Added 28.61%
21,791 $29,000
Q2 2023

Aug 14, 2023
BUY
$2.13 - $7.13 $14,319 - $47,934
6,723 Added 65.78%
16,943 $41,000
Q1 2023

May 11, 2023
BUY
$5.52 - $9.23 $56,414 - $94,330
10,220 New
10,220 $58,000

Others Institutions Holding ACET

# of Institutions
72
Shares Held
59.2M
Call Options Held
4.2K
Put Options Held
6.7K
View Full List

About Adicet Bio, Inc.

ACET Quotes by TradingView
  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $39.6M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email